Table 1 OS with AML, non-APL, 1997 to... | American Society of Hematology

Table 1

OS with AML, non-APL, 1997 to 2006 (n = 2511)

Age, y	AML (non-APL), unselected, %				AML (non-APL), selected de novo, intensive treatment, PS 0-II, %				Ratio of selected/unselected
Age, y	n	2-year	5-year	Median days	n	2-year	5-year	Median days	n	2-year	5-year	Median
< 30	65	65	60	> 4000	44	72	63	> 4000	0.68	1.11	1.05	—
30-44	171	57	49	1747	120	72	60	> 4000	0.70	1.26	1.22	—
45-54	266	54	43	934	170	70	59	> 4000	0.64	1.30	1.37	—
55-64	423	36	23	396	208	58	36	1022	0.49	1.61	1.57	2.58
65-69	308	22	12	263	132	43	26	655	0.43	1.95	2.17	2.49
70-74	419	16	5	174	134	34	13	447	0.32	2.13	2.60	2.57
75-79	448	9	2	108	143	17	6	248	0.32	1.89	—	2.30
80-84	411	4	1	81	123	8	4	111	0.30	—	—	1.37

Age, y	AML (non-APL), unselected, %				AML (non-APL), selected de novo, intensive treatment, PS 0-II, %				Ratio of selected/unselected
Age, y	n	2-year	5-year	Median days	n	2-year	5-year	Median days	n	2-year	5-year	Median
< 30	65	65	60	> 4000	44	72	63	> 4000	0.68	1.11	1.05	—
30-44	171	57	49	1747	120	72	60	> 4000	0.70	1.26	1.22	—
45-54	266	54	43	934	170	70	59	> 4000	0.64	1.30	1.37	—
55-64	423	36	23	396	208	58	36	1022	0.49	1.61	1.57	2.58
65-69	308	22	12	263	132	43	26	655	0.43	1.95	2.17	2.49
70-74	419	16	5	174	134	34	13	447	0.32	2.13	2.60	2.57
75-79	448	9	2	108	143	17	6	248	0.32	1.89	—	2.30
80-84	411	4	1	81	123	8	4	111	0.30	—	—	1.37

— indicates not applicable.